About Bellipharma
Bellipharma is a private limited company (BV/SRL) based in Schaarbeek, founded in 2012. Its main activity is classified as "Detailhandel in farmaceutische producten". For the 2024 financial year, Bellipharma reported a loss of €19,063. The loss is larger than in 2023, when it was €18,720. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €28,379, up 387% on 2023. Equity stands at €223,865, a solvency ratio of 50%. In 2013 it was €144,764. 12 annual accounts are available, covering 2013 to 2024.
- Sectors
- Pharmacies
- Signals
-
Reporting lossesReporting losses € -15K
The company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.98The current ratio is below 1: may be insufficient to cover short-term debt.
Strong equityStrong equity € 224KStrong equity provides a buffer against setbacks.
Low riskLow risk 49.9%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 619Positive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 5KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 11.5%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2021
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
28K
|
€
6K
|
€
80K
|
€
145K
|
|
|
€
5K
|
€
6K
|
€
73K
|
€
135K
|
|
|
€
-19K
|
€
-19K
|
€
25K
|
€
99K
|
|
|
€
224K
|
€
243K
|
€
262K
|
€
237K
|
|
|
49.94%
|
60.54%
|
52.43%
|
50.36%
|
|
|
€
224K
|
€
158K
|
€
237K
|
€
234K
|
|
|
€
44K
|
€
33K
|
€
6K
|
€
11K
|
Publications 11
All publications- Statuten (Vertaling, Co?Rdinatie, Overige Wijzigingen, ?) - Wijziging Rechtsvorm - Benaming - Maatschappelijke Zetel - Ontslagen - Benoemingen 22/01/2026
- Ontslagen - Benoemingen 06/02/2017
- Benaming - Ontslagen - Benoemingen 21/09/2016
- Me. - Comptes Annuels 31.12.2015, App 24.06.2016, Dpt 19.08.2016 16450-0350-013 25/08/2016
- Maatschappelijke Zetel - Ontslagen - Benoemingen 26/07/2016
Frequently asked questions
Answers to the most common questions about Bellipharma, based on official government data and the filed annual accounts.
What is the VAT number of Bellipharma?
The VAT number of Bellipharma is BE0844.039.461.
What is the official website of Bellipharma?
The official website of Bellipharma is www.bellipharma.be.
When was Bellipharma established?
Bellipharma was founded in 29-02-2012.
What is the official address of Bellipharma?
The official address of Bellipharma is Simon Bolivarlaan 21-23 Schaarbeek 1030.
What is the legal form of Bellipharma?
The juridical form of Bellipharma is Private limited company (BV/SRL).
What is the annual revenue of Bellipharma?
The 2024 accounts of Bellipharma do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Bellipharma a reliable company?
Bellipharma is a registered Rechtspersoon with company number 0844.039.461 and can be verified through the official CBE database.
What is the credit limit of Bellipharma?
The estimated credit limit of Bellipharma is €13,613.
Is Bellipharma still active?
Bellipharma currently has the status "Normal situation" and is active.